Boehringer Ingelheim Buys Cellomics Automated Cell Imaging Technology

Aug 03, 2001

NEW YORK, Aug. 3 – Cellomics has sold its ArrayScan HCS system for imaging cells to Boehringer Ingelheim Pharmaceuticals, Cellomics said on Friday.

The giant German pharma company will use the system to automate its drug-discovery process, the company said in a statement.

Financial details were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Links Between Them

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

Retaliation Claim

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

Good Samples Under the Glass

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

This Week in PNAS

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.

Main menu